Recent studies demonstrated that some ALS-related UBQLN2 mutants exhibited defects in ubiquitin-binding abilities that resulted in a failure to deliver ubiquitinated substrates to proteasomes for degradation [46]. Here, UBQLN2 is linked to amyotrophic lateral sclerosis.